MétaCan
Menu
← Back to cohort
Record W4410711764 · doi:10.1038/s41467-025-59979-6

Analysis of more than 400,000 women provides case-control evidence for BRCA1 and BRCA2 variant classification

2025· article· en· W4410711764 on OpenAlexafffund
Maria Zanti, Denise G O'Mahony, Michael T. Parsons, Leila Dorling, Joe Dennis, Nicholas Boddicker, Wenan Chen, Chunling Hu, Marc Naven, Kristia Yiangou, Thomas U. Ahearn, Christine B. Ambrosone, Irene L. Andrulis, Antonis C. Antoniou, Paul L. Auer, Caroline Baynes, Clara Bodelón, Natalia Bogdanova, Stig E. Bojesen, Manjeet K. Bolla, Kristen D. Brantley, Nicola J. Camp, Archie Campbell, Jose E. Castelao, Melissa H. Cessna, Jenny Chang‐Claude, Fei Chen, Georgia Chenevix‐Trench, Don Conroy, Kamila Czene, Arcangela De Nicolo, Susan M. Domchek, Thilo Dörk, Alison M. Dunning, A. Heather Eliassen, D. Gareth Evans, Peter A. Fasching, Jonine D. Figueroa, Henrik Flyger, Manuela Gago-Domínguez, Montserrat García‐Closas, Gord Glendon, Anna González‐Neira, Felix Graßmann, Andreas Hadjisavvas, Christopher A. Haiman, Ute Hamann, Steven N. Hart, Weang-Kee Ho, Reiner Hoppe, Sacha J. Howell, Anna Jakubowska, Elza K. Khusnutdinova, Yon‐Dschun Ko, Peter Kraft, James V. Lacey, Jingmei Li, Geok Hoon Lim, Artitaya Lophatananon, Craig Luccarini, Arto Mannermaa, Marı́a Elena Martı́nez, Dimitriοs Mavroudis, Roger L. Milne, Kenneth Muir, Katherine L. Nathanson, Rocío Núñez‐Torres, Nadia Obi, Janet E. Olson, Julie R. Palmer, Mihalis I. Panayiotidis, Alpa V. Patel, Paul D.P. Pharoah, Eric C. Polley, Muhammad Usman Rashid, Kathryn J. Ruddy, Emmanouil Saloustros, Elinor J. Sawyer, Marjanka K. Schmidt, Melissa C. Southey, Veronique Kiak Mien Tan, Soo‐Hwang Teo, Lauren R. Teras, Diana Torres, Amy Trentham-Dietz, Thérèse Truong, Celine M. Vachon, Qin Wang, Jeffrey N. Weitzel, Siddhartha Yadav, Song Yao, Gary Zirpoli, Melissa Cline, Peter Devilee, Sean V. Tavtigian, David E. Goldgar, Fergus J. Couch, Douglas F. Easton, Amanda B. Spurdle, Kyriaki Michailidou

Bibliographic record

VenueNature Communications · 2025
Typearticle
Languageen
FieldBiochemistry, Genetics and Molecular Biology
TopicBRCA gene mutations in cancer
Canadian institutionsLunenfeld-Tanenbaum Research InstituteUniversity of TorontoMount Sinai Hospital
FundersMedical Research and Materiel CommandNIHR Cambridge Biomedical Research CentreServicio Gallego de SaludInstituto de Salud Carlos IIINational Medical Research CouncilCancer Council TasmaniaNational Health and Medical Research CouncilMedical Research CouncilCanadian Institutes of Health ResearchProgramme Grants for Applied ResearchManchester Biomedical Research CentreU.S. ArmyNational Institutes of HealthNational University Health SystemXunta de GaliciaAgence Nationale de Sécurité Sanitaire de l’Alimentation, de l’Environnement et du TravailCenters for Disease Control and PreventionInstitut National Du CancerNational Center for Chronic Disease Prevention and Health PromotionDeutsche KrebshilfeMedizinischen Hochschule HannoverUniversity of CreteStockholms Läns LandstingKuopion Yliopistollinen SairaalaKarolinska InstitutetChief Scientist Office, Scottish Government Health and Social Care DirectorateBundesministerium für Bildung und ForschungMinisterio de Economía y CompetitividadRussian Foundation for Basic ResearchAgence Nationale de la RechercheDeutsche Gesetzliche UnfallversicherungGentofte HospitalDeutsche ForschungsgemeinschaftAlexander von Humboldt-StiftungHuntsman Cancer FoundationRobert Bosch StiftungAgency for Science, Technology and ResearchCancer Research UKNational University of SingaporeNational Institute for Health and Care ResearchNational Research Foundation SingaporeNational Research FoundationNational Breast Cancer FoundationEngineering and Physical Sciences Research CouncilEuropean CommissionResearch Promotion FoundationKing's College LondonGovernment of CanadaUniversity of CambridgeMinisterio de Sanidad, Servicios Sociales e IgualdadScottish Funding CouncilCancerfondenNational Cancer InstituteCancer Institute NSWFondation de FranceNIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer ResearchBreast Cancer CampaignNorges ForskningsrådScottish GovernmentDivision of Cancer Prevention, National Cancer InstituteBreast Cancer Research TrustWellcome TrustFondation du cancer du sein du QuébecNational Heart, Lung, and Blood InstituteItä-Suomen YliopistoCenter for Agroforestry, University of MissouriGenome CanadaDeutsches KrebsforschungszentrumMinisterie van Volksgezondheid, Welzijn en SportUniversity of California, San FranciscoU.S. Department of Health and Human ServicesUniversity of Wisconsin Carbone Cancer CenterDepartment of Health and Social CareDivision of Cancer Epidemiology and Genetics, National Cancer InstituteHuntsman Cancer InstituteUniversity of CaliforniaCancer Council VictoriaMinistry of Science and Higher Education of the Russian FederationCalifornia Department of Public HealthSundhed og Sygdom, Det Frie ForskningsrådCancer Council NSWSusan G. Komen for the CureUniversity of Southern CaliforniaCancer Council South AustraliaAmerican Cancer Society
KeywordsComputational biologyComputer scienceMedicineGeneticsBiology

Abstract

fetched live from OpenAlex

Clinical genetic testing identifies variants causal for hereditary cancer, information that is used for risk assessment and clinical management. Unfortunately, some variants identified are of uncertain clinical significance (VUS), complicating patient management. Case-control data is one evidence type used to classify VUS. As an initiative of the Evidence-based Network for the Interpretation of Germline Mutant Alleles (ENIGMA) Analytical Working Group we analyze germline sequencing data of BRCA1 and BRCA2 from 96,691 female breast cancer cases and 302,116 controls from three studies: the BRIDGES study of the Breast Cancer Association Consortium, the Cancer Risk Estimates Related to Susceptibility consortium, and the UK Biobank. We observe 11,207 BRCA1 and BRCA2 variants, with 6909 being coding, covering 23.4% of BRCA1 and BRCA2 VUS in ClinVar and 19.2% of ClinVar curated (likely) benign or pathogenic variants. Case-control likelihood ratio (ccLR) evidence is highly consistent with ClinVar assertions for (likely) benign or pathogenic variants; exhibiting 99.1% sensitivity and 95.3% specificity for BRCA1 and 93.3% sensitivity and 86.6% specificity for BRCA2. This approach provides case-control evidence for 787 unclassified variants; these include 579 with strong or moderate benign evidence and 10 with strong pathogenic evidence for which ccLR evidence is sufficient to alter clinical classification.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.012
metaresearch head score (Gemma)0.033
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.012
Threshold uncertainty score0.066

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0120.033
Meta-epidemiology (narrow)0.0010.001
Meta-epidemiology (broad)0.0010.001
Bibliometrics0.0060.007
Science and technology studies0.0010.001
Scholarly communication0.0010.001
Open science0.0010.001
Research integrity0.0010.001
Insufficient payload (model declined to judge)0.0060.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.029
GPT teacher head0.356
Teacher spread0.327 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations8
Published2025
Admission routes2
Has abstractyes

Explore more

Same venueNature Communications→Same topicBRCA gene mutations in cancer→French-language works237,207→